Economic analyses of human genetics services: A systematic review

This publication has 18 references indexed in Scilit:

• A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
  Pharmacogenomics, 2004
• Cost-effectiveness of testing for hypercoagulability and effects on treatment strategies in patients with deep vein thrombosis
  The American Journal of Medicine, 2004
• HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
  Journal of Clinical Oncology, 2004
• Cost utility of prenatal diagnosis and the risk-based threshold
  The Lancet, 2004
• Newborn Screening by Tandem Mass Spectrometry for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: A Cost-Effectiveness Analysis
  Pediatrics, 2003
• The Cost‐Effectiveness of Interleukin‐1 Genetic Testing for Periodontal Disease
  The Journal of Periodontology, 2002
• Will Genetic Testing Alter the Management of Disease Caused by Infectious Agents? A Cost‐Effectiveness Analysis of Gene‐Testing Strategies for Prevention of Rheumatic Fever
  Clinical Infectious Diseases, 2002
• Testing for Factor V Leiden in Patients with Pulmonary or Venous Thromboembolism: A Cost-Effectiveness Analysis
  Medical Decision Making, 2002
• Prenatal Screening for Cystic Fibrosis Carriers: An Economic Evaluation
  American Journal of Human Genetics, 1998
• Guidelines for authors and peer reviewers of economic submissions to the BMJ
  BMJ, 1996